{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-chemo-neuropathy","title":"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review","body":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but trades off any direct support for repair pathways. Evidence for CIPN is limited and inconsistent.\n\n## How these fit together\n\nSingle-compound focus — PT-141 addresses sexual / CNS arousal pathways. Gabapentin or pregabalin addresses pain signal suppression. They target separate layers with no overlapping repair mechanism described in available sources. Any combined use would require separate evaluation of each layer's contribution to your symptoms.\n\n## What the evidence actually shows\n\nNo human clinical trials have tested PT-141 or bremelanotide in CIPN patients (tier: human - none). No rat or mouse studies of PT-141 in chemotherapy neuropathy models appear in indexed literature (tier: preclinical - none). All discussion of PT-141 in this context remains mechanistic or speculative based on its established use in hypoactive sexual desire disorder.\n\nGabapentinoids show limited evidence in CIPN. A 2024 meta-analysis found pregabalin did not significantly prevent CIPN on average pain scores and yielded inconsistent results for treatment (tier: human). ASCO guidelines note that gabapentin or pregabalin may be considered for positive sensory symptoms but with limited scientific evidence of benefit.\n\n## What scientists say\n\nResearchers describe PT-141 as a central melanocortin agonist approved for sexual desire disorders. No publications link it to neuroprotection, axon regeneration, or CIPN models. Neuropathy experts emphasize the absence of disease-modifying agents for CIPN and the reliance on symptomatic drugs with modest, variable effects.\n\n## What people say on Reddit\n\nAnecdotal posts rarely mention PT-141 in CIPN contexts. One user in a small-fiber neuropathy thread noted trying PT-141 among other peptides but attributed any improvement to different compounds and explicitly stated PT-141 is oriented toward sexual arousal rather than pain reduction (tier: anecdotal). Other threads discuss PT-141 for post-cancer sexual dysfunction without reference to neuropathy symptoms.\n\n## What people say on X\n\nNo relevant public posts linking PT-141 to CIPN or chemotherapy neuropathy were identified in available searches.\n\n## What we do not know\n\nWhether melanocortin agonism could influence nerve repair pathways in humans with CIPN is unknown. No dose-response, safety, or efficacy data exist for this use. Long-term effects on damaged peripheral nerves remain unstudied.\n\n## Safety and limits\n\nPT-141 carries known side effects including nausea, flushing, and blood-pressure changes from its approved use. Gabapentinoids can cause dizziness, sedation, and require dose adjustment in some patients. Both approaches address symptoms or specific CNS functions rather than reversing chemotherapy-induced nerve damage. Readers should consult qualified clinicians for individualized assessment; this review contains no treatment recommendations.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-chemo-neuropathy/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials have tested PT-141 for CIPN.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of direct human data for the primary compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Provides graded evidence on the standard symptomatic drug mentioned.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the if-then logic in the compound's established mechanism.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.","section":"Why Gabapentin / pregabalin matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the suppression versus repair distinction for the reader.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates user reports from any clinical data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent, demonstrated efficacy in improving male and female sexual dysfunction","summary":"Review of bremelanotide mechanism and approval data; no mention of neuropathy applications.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"0c022fc538f1de8537b8bcc4c7c759a605af2bdb51ff0ece39e8e63e042ba8fb"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","summary":"2024 meta-analysis showing inconsistent results for gabapentinoids in CIPN.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"verified","prev":"0c022fc538f1de8537b8bcc4c7c759a605af2bdb51ff0ece39e8e63e042ba8fb","hash":"990c858f5c6e823bf2e7ee2ad36082f5d9628292f4fce19cc9a55d9df509f172"},{"id":"s3","type":"review","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","summary":"Confirms central melanocortin mechanism.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"http_403","quote_status":"unverified","prev":"990c858f5c6e823bf2e7ee2ad36082f5d9628292f4fce19cc9a55d9df509f172","hash":"0d11326ee0e7f15aa6b9e4afc2c2445c818adfab43dac32efc7cb216b6c02018"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","quote":"PT-141 is more sexual/arousal. Wouldn’t recommend that if your focus is on pain reduction.","summary":"User comment distinguishing PT-141 from pain-focused peptides.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"unverified","prev":"0d11326ee0e7f15aa6b9e4afc2c2445c818adfab43dac32efc7cb216b6c02018","hash":"dfbd76cb8ad6b18dfcac986a41eaceec48918b94bbc240d02fc91a696751a5cf"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:20:03.699Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but trades off any direct support for repair pathways. Evidence for CIPN is limited and inconsistent.\n\n## How these fit together\n\nSingle-compound focus — PT-141 addresses sexual / CNS arousal pathways. Gabapentin or pregabalin addresses pain signal suppression. They target separate layers with no overlapping repair mechanism described in available sources. Any combined use would require separate evaluation of each layer's contribution to your symptoms.\n\n## What the evidence actually shows\n\nNo human clinical trials have tested PT-141 or bremelanotide in CIPN patients (tier: human - none). No rat or mouse studies of PT-141 in chemotherapy neuropathy models appear in indexed literature (tier: preclinical - none). All discussion of PT-141 in this context remains mechanistic or speculative based on its established use in hypoactive sexual desire disorder.\n\nGabapentinoids show limited evidence in CIPN. A 2024 meta-analysis found pregabalin did not significantly prevent CIPN on average pain scores and yielded inconsistent results for treatment (tier: human). ASCO guidelines note that gabapentin or pregabalin may be considered for positive sensory symptoms but with limited scientific evidence of benefit.\n\n## What scientists say\n\nResearchers describe PT-141 as a central melanocortin agonist approved for sexual desire disorders. No publications link it to neuroprotection, axon regeneration, or CIPN models. Neuropathy experts emphasize the absence of disease-modifying agents for CIPN and the reliance on symptomatic drugs with modest, variable effects.\n\n## What people say on Reddit\n\nAnecdotal posts rarely mention PT-141 in CIPN contexts. One user in a small-fiber neuropathy thread noted trying PT-141 among other peptides but attributed any improvement to different compounds and explicitly stated PT-141 is oriented toward sexual arousal rather than pain reduction (tier: anecdotal). Other threads discuss PT-141 for post-cancer sexual dysfunction without reference to neuropathy symptoms.\n\n## What people say on X\n\nNo relevant public posts linking PT-141 to CIPN or chemotherapy neuropathy were identified in available searches.\n\n## What we do not know\n\nWhether melanocortin agonism could influence nerve repair pathways in humans with CIPN is unknown. No dose-response, safety, or efficacy data exist for this use. Long-term effects on damaged peripheral nerves remain unstudied.\n\n## Safety and limits\n\nPT-141 carries known side effects including nausea, flushing, and blood-pressure changes from its approved use. Gabapentinoids can cause dizziness, sedation, and require dose adjustment in some patients. Both approaches address symptoms or specific CNS functions rather than reversing chemotherapy-induced nerve damage. Readers should consult qualified clinicians for individualized assessment; this review contains no treatment recommendations.","claims":[{"id":"c1","text":"No human clinical trials have tested PT-141 for CIPN.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of direct human data for the primary compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Provides graded evidence on the standard symptomatic drug mentioned.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the if-then logic in the compound's established mechanism.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.","section":"Why Gabapentin / pregabalin matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the suppression versus repair distinction for the reader.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates user reports from any clinical data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent, demonstrated efficacy in improving male and female sexual dysfunction","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","quote":"PT-141 is more sexual/arousal. Wouldn’t recommend that if your focus is on pain reduction.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":23847,"tokens_out":2924,"cost":0.03711875,"prev_hash":"genesis","hash":"e4c746e3457ab142f5582c83a5fac8c4c304e301a8ca5cf9cf140a30b5f5c752"}],"provenance":[{"ts":"2026-06-30T01:20:03.699Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Chemo Neuropathy\nSlug: pt-141-chemo-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Chemotherapy-induced neuropathy (CIPN)\",\"condition_key\":\"chemo-neuropathy\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"gabapentin-lyrica\",\"name\":\"Gabapentin / pregabalin\",\"section_title\":\"Why Gabapentin / pregabalin matters for you\",\"steps\":[\"**Drug:** Gabapentin / pregabalin\",\"**What it does:** Masks neuropathic pain signal; does not repair nerve.\",\"**","response":"{\n  \"slug\": \"pt-141-chemo-neuropathy\",\n  \"title\": \"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\\n\\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n**Drug:** Gabapentin / pregabalin\\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but tra","tokens_in":23847,"tokens_out":2924,"cost":0,"prev":"genesis","hash":"02b14ca9275d8429c9b8600d4e283c5dd71092889f41123007a9c1570c56f500"},{"ts":"2026-07-17T02:41:04.767Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-chemo-neuropathy","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"02b14ca9275d8429c9b8600d4e283c5dd71092889f41123007a9c1570c56f500","hash":"9800b2ce322032f1592a3382c4c2b7d57b407e216ac78381373f54dcfd349110"}],"energy":{"passes":2,"tokens_in":23847,"tokens_out":2924,"tokens_total":26771,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"9800b2ce322032f1592a3382c4c2b7d57b407e216ac78381373f54dcfd349110"},"posted_at":"2026-06-29T21:32:51.842Z","created_at":"2026-06-29T21:32:51.842Z","updated_at":"2026-07-17T02:41:04.767Z","machine":{"shape":"article.machine/v1","slug":"pt-141-chemo-neuropathy","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-chemo-neuropathy","json":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy","bundle":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-chemo-neuropathy","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-chemo-neuropathy\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-chemo-neuropathy\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-chemo-neuropathy\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-chemo-neuropathy","json":"/api/articles/pt-141-chemo-neuropathy","markdown":"/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown","skill":"/api/articles/pt-141-chemo-neuropathy/skill","topology":"/api/articles/pt-141-chemo-neuropathy/topology","versions":"/api/articles/pt-141-chemo-neuropathy/revisions","invocations":"/api/articles/pt-141-chemo-neuropathy/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-chemo-neuropathy","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"7b873ec00dff3804a27528a93f39dc55e7970c7dd1658c9817c2175c0a444706","object":{"object_type":"article-object","identity":{"id":"article:pt-141-chemo-neuropathy","slug":"pt-141-chemo-neuropathy","title":"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-chemo-neuropathy","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-chemo-neuropathy/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-chemo-neuropathy\ndescription: Apply the PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-chemo-neuropathy). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-chemo-neuropathy.\n- Read claims and relationships at /api/articles/pt-141-chemo-neuropathy/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Chemotherapy-induced neuropathy CIPN Chemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, b\n\n## Representations\n\n- Human: /a/pt-141-chemo-neuropathy\n- JSON: /api/articles/pt-141-chemo-neuropathy\n- Relationships: /api/articles/pt-141-chemo-neuropathy/topology\n- History: /api/articles/pt-141-chemo-neuropathy/revisions\n"},"json":{"route":"/api/articles/pt-141-chemo-neuropathy","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","chemo","neuropathy"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-chemo-neuropathy/invocations?status=success","failure_events":"/api/articles/pt-141-chemo-neuropathy/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-chemo-neuropathy","title":"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review","body":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but trades off any direct support for repair pathways. Evidence for CIPN is limited and inconsistent.\n\n## How these fit together\n\nSingle-compound focus — PT-141 addresses sexual / CNS arousal pathways. Gabapentin or pregabalin addresses pain signal suppression. They target separate layers with no overlapping repair mechanism described in available sources. Any combined use would require separate evaluation of each layer's contribution to your symptoms.\n\n## What the evidence actually shows\n\nNo human clinical trials have tested PT-141 or bremelanotide in CIPN patients (tier: human - none). No rat or mouse studies of PT-141 in chemotherapy neuropathy models appear in indexed literature (tier: preclinical - none). All discussion of PT-141 in this context remains mechanistic or speculative based on its established use in hypoactive sexual desire disorder.\n\nGabapentinoids show limited evidence in CIPN. A 2024 meta-analysis found pregabalin did not significantly prevent CIPN on average pain scores and yielded inconsistent results for treatment (tier: human). ASCO guidelines note that gabapentin or pregabalin may be considered for positive sensory symptoms but with limited scientific evidence of benefit.\n\n## What scientists say\n\nResearchers describe PT-141 as a central melanocortin agonist approved for sexual desire disorders. No publications link it to neuroprotection, axon regeneration, or CIPN models. Neuropathy experts emphasize the absence of disease-modifying agents for CIPN and the reliance on symptomatic drugs with modest, variable effects.\n\n## What people say on Reddit\n\nAnecdotal posts rarely mention PT-141 in CIPN contexts. One user in a small-fiber neuropathy thread noted trying PT-141 among other peptides but attributed any improvement to different compounds and explicitly stated PT-141 is oriented toward sexual arousal rather than pain reduction (tier: anecdotal). Other threads discuss PT-141 for post-cancer sexual dysfunction without reference to neuropathy symptoms.\n\n## What people say on X\n\nNo relevant public posts linking PT-141 to CIPN or chemotherapy neuropathy were identified in available searches.\n\n## What we do not know\n\nWhether melanocortin agonism could influence nerve repair pathways in humans with CIPN is unknown. No dose-response, safety, or efficacy data exist for this use. Long-term effects on damaged peripheral nerves remain unstudied.\n\n## Safety and limits\n\nPT-141 carries known side effects including nausea, flushing, and blood-pressure changes from its approved use. Gabapentinoids can cause dizziness, sedation, and require dose adjustment in some patients. Both approaches address symptoms or specific CNS functions rather than reversing chemotherapy-induced nerve damage. Readers should consult qualified clinicians for individualized assessment; this review contains no treatment recommendations.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-chemo-neuropathy/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials have tested PT-141 for CIPN.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of direct human data for the primary compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Provides graded evidence on the standard symptomatic drug mentioned.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the if-then logic in the compound's established mechanism.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.","section":"Why Gabapentin / pregabalin matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the suppression versus repair distinction for the reader.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates user reports from any clinical data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent, demonstrated efficacy in improving male and female sexual dysfunction","summary":"Review of bremelanotide mechanism and approval data; no mention of neuropathy applications.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"0c022fc538f1de8537b8bcc4c7c759a605af2bdb51ff0ece39e8e63e042ba8fb"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","summary":"2024 meta-analysis showing inconsistent results for gabapentinoids in CIPN.","claim_ids":["c2","c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"verified","prev":"0c022fc538f1de8537b8bcc4c7c759a605af2bdb51ff0ece39e8e63e042ba8fb","hash":"990c858f5c6e823bf2e7ee2ad36082f5d9628292f4fce19cc9a55d9df509f172"},{"id":"s3","type":"review","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","summary":"Confirms central melanocortin mechanism.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"http_403","quote_status":"unverified","prev":"990c858f5c6e823bf2e7ee2ad36082f5d9628292f4fce19cc9a55d9df509f172","hash":"0d11326ee0e7f15aa6b9e4afc2c2445c818adfab43dac32efc7cb216b6c02018"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","quote":"PT-141 is more sexual/arousal. Wouldn’t recommend that if your focus is on pain reduction.","summary":"User comment distinguishing PT-141 from pain-focused peptides.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:20:03.046Z","link_status":"ok","quote_status":"unverified","prev":"0d11326ee0e7f15aa6b9e4afc2c2445c818adfab43dac32efc7cb216b6c02018","hash":"dfbd76cb8ad6b18dfcac986a41eaceec48918b94bbc240d02fc91a696751a5cf"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:20:03.699Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\n\n## Why Gabapentin / pregabalin matters for you\n\n**Drug:** Gabapentin / pregabalin\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but trades off any direct support for repair pathways. Evidence for CIPN is limited and inconsistent.\n\n## How these fit together\n\nSingle-compound focus — PT-141 addresses sexual / CNS arousal pathways. Gabapentin or pregabalin addresses pain signal suppression. They target separate layers with no overlapping repair mechanism described in available sources. Any combined use would require separate evaluation of each layer's contribution to your symptoms.\n\n## What the evidence actually shows\n\nNo human clinical trials have tested PT-141 or bremelanotide in CIPN patients (tier: human - none). No rat or mouse studies of PT-141 in chemotherapy neuropathy models appear in indexed literature (tier: preclinical - none). All discussion of PT-141 in this context remains mechanistic or speculative based on its established use in hypoactive sexual desire disorder.\n\nGabapentinoids show limited evidence in CIPN. A 2024 meta-analysis found pregabalin did not significantly prevent CIPN on average pain scores and yielded inconsistent results for treatment (tier: human). ASCO guidelines note that gabapentin or pregabalin may be considered for positive sensory symptoms but with limited scientific evidence of benefit.\n\n## What scientists say\n\nResearchers describe PT-141 as a central melanocortin agonist approved for sexual desire disorders. No publications link it to neuroprotection, axon regeneration, or CIPN models. Neuropathy experts emphasize the absence of disease-modifying agents for CIPN and the reliance on symptomatic drugs with modest, variable effects.\n\n## What people say on Reddit\n\nAnecdotal posts rarely mention PT-141 in CIPN contexts. One user in a small-fiber neuropathy thread noted trying PT-141 among other peptides but attributed any improvement to different compounds and explicitly stated PT-141 is oriented toward sexual arousal rather than pain reduction (tier: anecdotal). Other threads discuss PT-141 for post-cancer sexual dysfunction without reference to neuropathy symptoms.\n\n## What people say on X\n\nNo relevant public posts linking PT-141 to CIPN or chemotherapy neuropathy were identified in available searches.\n\n## What we do not know\n\nWhether melanocortin agonism could influence nerve repair pathways in humans with CIPN is unknown. No dose-response, safety, or efficacy data exist for this use. Long-term effects on damaged peripheral nerves remain unstudied.\n\n## Safety and limits\n\nPT-141 carries known side effects including nausea, flushing, and blood-pressure changes from its approved use. Gabapentinoids can cause dizziness, sedation, and require dose adjustment in some patients. Both approaches address symptoms or specific CNS functions rather than reversing chemotherapy-induced nerve damage. Readers should consult qualified clinicians for individualized assessment; this review contains no treatment recommendations.","claims":[{"id":"c1","text":"No human clinical trials have tested PT-141 for CIPN.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of direct human data for the primary compound.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Provides graded evidence on the standard symptomatic drug mentioned.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the if-then logic in the compound's established mechanism.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.","section":"Why Gabapentin / pregabalin matters for you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the suppression versus repair distinction for the reader.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Separates user reports from any clinical data.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:20:03.332Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide (PT-141) is a melanocortinergic agent, demonstrated efficacy in improving male and female sexual dysfunction","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38936970/","title":"Gabapentinoids for chemotherapy-induced peripheral neuropathy","quote":"There is limited evidence to support the use of gabapentinoids in CIPN.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","quote":"PT-141 is more sexual/arousal. Wouldn’t recommend that if your focus is on pain reduction.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":23847,"tokens_out":2924,"cost":0.03711875,"prev_hash":"genesis","hash":"e4c746e3457ab142f5582c83a5fac8c4c304e301a8ca5cf9cf140a30b5f5c752"}],"provenance":[{"ts":"2026-06-30T01:20:03.699Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Chemo Neuropathy\nSlug: pt-141-chemo-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Chemotherapy-induced neuropathy (CIPN)\",\"condition_key\":\"chemo-neuropathy\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"gabapentin-lyrica\",\"name\":\"Gabapentin / pregabalin\",\"section_title\":\"Why Gabapentin / pregabalin matters for you\",\"steps\":[\"**Drug:** Gabapentin / pregabalin\",\"**What it does:** Masks neuropathic pain signal; does not repair nerve.\",\"**","response":"{\n  \"slug\": \"pt-141-chemo-neuropathy\",\n  \"title\": \"PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\\n\\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant layer. No data connect melanocortin activation to peripheral nerve regeneration or axon repair in CIPN. The logic chain stops at the known mechanism: central arousal signaling, not peripheral tissue repair.\\n\\n## Why Gabapentin / pregabalin matters for you\\n\\n**Drug:** Gabapentin / pregabalin\\n**What it does:** Masks neuropathic pain signal; does not repair nerve.\\n**Therefore for you:** This drug suppresses a signal. It can reduce pain perception and improve sleep or daily function while the underlying nerve damage remains. Symptom relief may lower overall stress on the nervous system but tra","tokens_in":23847,"tokens_out":2924,"cost":0,"prev":"genesis","hash":"02b14ca9275d8429c9b8600d4e283c5dd71092889f41123007a9c1570c56f500"},{"ts":"2026-07-17T02:41:04.767Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-chemo-neuropathy","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"02b14ca9275d8429c9b8600d4e283c5dd71092889f41123007a9c1570c56f500","hash":"9800b2ce322032f1592a3382c4c2b7d57b407e216ac78381373f54dcfd349110"}],"energy":{"passes":2,"tokens_in":23847,"tokens_out":2924,"tokens_total":26771,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"9800b2ce322032f1592a3382c4c2b7d57b407e216ac78381373f54dcfd349110"},"posted_at":"2026-06-29T21:32:51.842Z","created_at":"2026-06-29T21:32:51.842Z","updated_at":"2026-07-17T02:41:04.767Z","machine":{"shape":"article.machine/v1","slug":"pt-141-chemo-neuropathy","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-chemo-neuropathy","json":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy","bundle":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-chemo-neuropathy","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-chemo-neuropathy\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-chemo-neuropathy\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-chemo-neuropathy\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-chemo-neuropathy","json":"/api/articles/pt-141-chemo-neuropathy","markdown":"/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown","skill":"/api/articles/pt-141-chemo-neuropathy/skill","topology":"/api/articles/pt-141-chemo-neuropathy/topology","versions":"/api/articles/pt-141-chemo-neuropathy/revisions","invocations":"/api/articles/pt-141-chemo-neuropathy/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-chemo-neuropathy","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"7b873ec00dff3804a27528a93f39dc55e7970c7dd1658c9817c2175c0a444706"}}}